Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Agenus To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Agenus between January 23, 2023 and July 17, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi […]
NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Extreme Networks, Inc. (NASDAQ: EXTR) and certain of the Company’s senior executives. If you invested in Extreme, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/extreme-networks-inc. Investors have until
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Sage To Contact Him Directly To Discuss Their Options NEW YORK CITY, NY / ACCESSWIRE / October 13, 2024 / If you suffered losses exceeding $75,000 in Sage between April 12, 2021 and July 23, 2024 and
NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ardelyx, Inc. (NASDAQ: ARDX) between October 31, 2023 and July 1, 2024, both dates inclusive (the “Class Period”), of the important October 15, 2024 lead plaintiff deadline. SO WHAT: If you purchased
NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) — Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Visa Inc. (NYSE: V) resulting from allegations that Visa may have issued materially misleading business information to the investing public. So What: If you purchased Visa
NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) — Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Joint Stock Company Kaspi.kz (NASDAQ: KSPI) resulting from allegations that Kaspi.kz may have issued materially misleading business information to the investing public. So What: If you
NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Super Micro Computer, Inc. (NASDAQ: SMCI) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Super Micro Computer, you are
NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ: DXCM) and certain of the Company’s senior executives. If you invested in DexCom, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/dexcom-inc. Investors have until October
NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elanco Animal Health Incorporated (NYSE:ELAN) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Elanco, you are encouraged to obtain
NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ: ADMA) for potential violations of the federal securities laws. If you invested in ADMA Biologics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/adma-biologics-inc. Why Did ADMA Biologics’s Stock